Showing results (191-200 of 235) with videos related to
Sort By:
Pageof 24
Iscience|April 25, 2023
The human E3 ligase RNF185 is a regulator of the SARS-CoV-2 envelope proteinCharles Zou, Hojong Yoon, Paul M C Park, et al.Science Translational Medicine|May 27, 2026
Efficacy and safety of durcabtagene autoleucel in a phase 1 trial for patients with relapsed/refractory multiple myelomaAdam S Sperling, Benjamin A Derman, Sarah Nikiforow, et al.American Journal of Hematology|November 10, 2017
A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemiaDaniel J DeAngelo, Andrew M Brunner, Lillian Werner, et al.Blood|September 20, 2014
Differential and limited expression of mutant alleles in multiple myelomaNaim U Rashid, Adam S Sperling, Niccolo Bolli, et al.Iscience|March 24, 2025
Identification of small molecule inhibitors of PPM1D using an integrated drug discovery platformSubrata Shaw, Wei Jiang, Jason Rush, et al.Current Topics in Medicinal Chemistry|July 27, 2022
OMICs Technologies for Natural Compounds-based Drug DevelopmentAbdullahi Tunde Aborode, Wireko Andrew Awuah, Tatiana Mikhailova, et al.Science Translational Medicine|January 7, 2021
Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomideMax Jan, Irene Scarfò, Rebecca C Larson, et al.Cancer|February 15, 2022
Quality of life, psychological distress, and prognostic perceptions in patients with multiple myelomaElizabeth K O'Donnell, Yael N Shapiro, Andrew J Yee, et al.JCO Precision Oncology|January 18, 2024
Cellular Mass Response to Therapy Correlates With Clinical Response for a Range of MalignanciesMark M Stevens, Robert J Kimmerling, Selim Olcum, et al.Nature|November 19, 2020
Small-molecule-induced polymerization triggers degradation of BCL6Mikołaj Słabicki, Hojong Yoon, Jonas Koeppel, et al.Pageof 24